Replimune Group, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.86 | -$0.86 | -$0.86 |
| Q2 2024 | 6 | -$0.88 | -$0.76 | -$0.82 |
| Q3 2024 | 2 | -$0.81 | -$0.81 | -$0.81 |
| Q1 2025 | 5 | -$0.78 | -$0.78 | -$0.78 |
| Q2 2025 | 5 | -$0.71 | -$0.71 | -$0.71 |
| Q3 2025 | 5 | -$0.70 | -$0.70 | -$0.70 |
| Q4 2025 | 5 | -$0.62 | -$0.62 | -$0.62 |
| Q1 2026 | 2 | -$0.59 | -$0.59 | -$0.59 |
| Q2 2026 | 2 | -$0.40 | -$0.40 | -$0.40 |
| Q3 2026 | 2 | -$0.35 | -$0.35 | -$0.35 |
| Q4 2026 | 2 | -$0.30 | -$0.30 | -$0.30 |
| Q1 2027 | 2 | -$0.26 | -$0.26 | -$0.26 |
| Q2 2027 | 2 | -$0.21 | -$0.21 | -$0.21 |
| Q3 2027 | 2 | -$0.15 | -$0.15 | -$0.15 |
| Q4 2027 | 2 | -$0.09 | -$0.09 | -$0.09 |
| Q1 2028 | 5 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2028 | 5 | -$0.00 | -$0.00 | -$0.00 |
| Q3 2028 | 5 | $0.06 | $0.06 | $0.06 |
| Q4 2028 | 5 | $0.10 | $0.10 | $0.10 |
Replimune Group, Inc. Earnings Date And Information
Replimune Group, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.78 earnings per share for the quarter, topping analysts' consensus estimates of $-0.88 by $0.1. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Replimune Group, Inc. has generated $-3 earnings per share over the last year ($-3.24 diluted earnings per share) and currently has a price-to-earnings ratio of -3.78. Replimune Group, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based on prior year's report dates.
Replimune Group, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q1 2025 | -$0.88 | -$0.78 | 0.1 | $0 | $0 |
| 05/16/2024 | Q4 2024 | -$0.86 | -$0.90 | -0.04 | $4.04 M | |
| 02/08/2024 | Q3 2024 | -$0.94 | -$0.77 | 0.17 | $0 | |
| 11/07/2023 | Q2 2024 | -$0.80 | -$0.90 | -0.1 | $0 | |
| 08/03/2023 | Q1 2024 | -$0.85 | -$0.75 | 0.1 | $0 | |
| 05/18/2023 | Q4 2023 | -$0.66 | -$0.87 | -0.21 | $0 | |
| 02/09/2023 | Q3 2023 | -$0.77 | -$0.69 | 0.08 | $0 | |
| 11/03/2022 | Q2 2023 | -$0.78 | -$0.79 | -0.01 | $0 | |
| 08/04/2022 | Q1 2023 | -$0.63 | -$0.78 | -0.15 | $0 | |
| 05/19/2022 | Q4 2022 | -$0.60 | -$0.67 | -0.07 | $0 | |
| 02/03/2022 | Q3 2022 | -$0.58 | -$0.57 | 0.01 | $0 | |
| 11/04/2021 | Q2 2022 | -$0.55 | -$0.56 | -0.01 | $0 | |
| 08/06/2021 | Q1 2022 | -$0.45 | -$0.53 | -0.08 | $0 | |
| 05/20/2021 | Q4 2021 | -$0.46 | $0 | |||
| 02/04/2021 | Q3 2021 | -$0.41 | -$0.44 | -0.03 | $0 | |
| 11/05/2020 | Q2 2021 | -$0.43 | -$0.46 | -0.03 | $0 | |
| 08/07/2020 | Q1 2021 | -$0.45 | -$0.44 | 0.01 | $0 | |
| 06/03/2020 | Q4 2020 | -$0.41 | $0 | |||
| 02/13/2020 | Q3 2020 | -$0.36 | -$0.46 | -0.1 | $0 | |
| 11/12/2019 | Q2 2020 | -$0.35 | $0 |
Replimune Group, Inc. Earnings: Frequently Asked Questions
-
When is Replimune Group, Inc.'s earnings date?
Replimune Group, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based off last year's report dates.
-
Did Replimune Group, Inc. beat their earnings estimates last quarter?
In the previous quarter, Replimune Group, Inc. (:REPL) reported $-0.78 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.88 by $0.1.
-
How can I listen to Replimune Group, Inc.'s earnings conference call?
The conference call for Replimune Group, Inc.'s latest earnings report can be listened to online.
-
How can I read Replimune Group, Inc.'s conference call transcript?
The conference call transcript for Replimune Group, Inc.'s latest earnings report can be read online.
-
How much profit does Replimune Group, Inc. generate each year?
Replimune Group, Inc. (:REPL) has a recorded net income of $0. Replimune Group, Inc. has generated $-3.24 earnings per share over the last four quarters.
-
What is Replimune Group, Inc.'s price-to-earnings ratio?
Replimune Group, Inc. (:REPL) has a price-to-earnings ratio of -3.78 and price/earnings-to-growth ratio is 4.18.
